<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03860103</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0049</org_study_id>
    <nct_id>NCT03860103</nct_id>
  </id_info>
  <brief_title>Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler (MICRODOPPLER PLACENTA)</brief_title>
  <official_title>Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler: an Observational Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jean-Luc GENNISSON</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anthony NOVELL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CNRS UMR 8081, Unviersité Paris Sud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To identify fetuses small for their gestational-age who have reached their appropriate growth
      potential from growth-restricted fetuses due to placental insufficiency is uneasy. Intra
      Uterine Growth Restriction (IUGR) increases the risk for indicated preterm delivery, neonatal
      mortality and morbidity. Therefore, improving the knowledge of the placental perfusion is
      essential to better identify and manage fetal chronic oxygen deprivation associated with
      placental insufficiency. Thus, the investigators propose to study placental microcirculation
      with a more efficient Doppler than conventional Doppler use in clinical practice. The
      Ultrafast Doppler is being able to map placental blood flow and could have potential impact
      in placental insufficiency diagnosis and prevention. Moreover, this Doppler could
      discriminate maternal and fetal vascularization.

      The hypothesis is that Ultrafast Doppler could help clinician to diagnose and manage
      preeclampsia and IUGR during pregnancy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative analysis (velocities) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler imaging</measure>
    <time_frame>from the 12 week of gestation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative analysis (flow rates) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler</measure>
    <time_frame>from the 12 week of gestation</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Preeclampsia and Intrauterine Growth Restriction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who accepted to participate in the study

          -  Woman over 18 years old

          -  Affiliated to a social security scheme

          -  Mono-fetal pregnancy

          -  Patients with normal pregnancy between 11 and 42 weeks of amenorrhea

          -  Patients hospitalized for preeclampsia and / or intrauterine growth retardation,
             beyond 20 weeks of amenorrhea

        Exclusion Criteria:

          -  Minors, adults under guardianship, protected persons

          -  Not affiliated to a social security scheme

          -  Multiple pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chloé Arthuis, Dr</last_name>
    <email>chloe.arthuis@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chloë Arthuis, PH</last_name>
      <email>chloe.arthuis@chu-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>February 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2019</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microDoppler</keyword>
  <keyword>placenta</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>intrauterine growth restriction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
    <mesh_term>Placental Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

